Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
January 9, 2013
WHITE BEAR LAKE, Minn.Chemi Nutra received no objection from FDA on the company's self-affirmed GRAS status for Alpha-Glyceryl Phosphoryl Choline (A-GPC). Chemi Nutra, the US branch of parent company Chemi S.p.A., manufactures AlphaSize® A-GPC for dietary supplements, beverages and shots.
The branded ingredient targets mental and exercise performance and provides sports nutrition, energy and anti-aging benefits. As a precursor of acetylcholine, the body's primary neurotransmitter, A-GPC is involved with brain function. The ingredient has been proven to improve mental clarity and tackle dementia.
Chemi S.p.A. is currently expanding production of AlphaSize A-GPC, said Scott Hagerman, Chemi Nutra president.
In Feb. 2012, Chemi Nutra received a U.S. patent for phosphatidylserine (PS) for testosterone management.
You May Also Like
Tianeptine sales spur another FDA warning, action by state lawmakersFeb 20, 2024
Formulating the future: The industry may not be ready for AI in product development, and AI might not be ready for the industry, eitherFeb 20, 2024
Beyond the primary outcome: How exploratory analysis can deliver unexpected new insightsFeb 19, 2024
Survey shows dietitians concerned about TikTok misinformationFeb 16, 2024